Insilico Medicine raises $255m in Series C
Insilico Medicine, an AI-based platform for drug development and discovery, announced $255m in Series C financing.
Share

The information on these pages is intended solely for the benefit of entrepreneurs and businesses seeking venture capital investment. Eight Roads does not offer and is not offering to provide investment advisory services nor is it offering to engage in any transactions in securities.